These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 9143680)
1. Human T cell leukemia virus type I (HTLV-I) and human diseases. Uchiyama T Annu Rev Immunol; 1997; 15():15-37. PubMed ID: 9143680 [TBL] [Abstract][Full Text] [Related]
4. Invasion of histiocytic sarcoma into the spinal cord of HTLV-1 tax transgenic mice with HTLV-1-associated myelopathy/tropical spastic paraparesis-like disease. Ohsugi T; Wakamiya M; Morikawa S; Matsuura K; Kumar JM; Kumasaka T; Yamaguchi K Oncol Res; 2013; 20(9):403-10. PubMed ID: 23924924 [TBL] [Abstract][Full Text] [Related]
5. Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites. Mori N; Ueda A; Ikeda S; Yamasaki Y; Yamada Y; Tomonaga M; Morikawa S; Geleziunas R; Yoshimura T; Yamamoto N Cancer Res; 2000 Sep; 60(17):4939-45. PubMed ID: 10987310 [TBL] [Abstract][Full Text] [Related]
6. [Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases]. Gessain A Bull Soc Pathol Exot; 2011 Aug; 104(3):167-80. PubMed ID: 21796326 [TBL] [Abstract][Full Text] [Related]
7. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice. Miyazato P; Yasunaga J; Taniguchi Y; Koyanagi Y; Mitsuya H; Matsuoka M J Virol; 2006 Nov; 80(21):10683-91. PubMed ID: 16943297 [TBL] [Abstract][Full Text] [Related]
8. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872 [TBL] [Abstract][Full Text] [Related]
9. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors. Kitazono T; Okazaki T; Araya N; Yamano Y; Yamada Y; Nakamura T; Tanaka Y; Inoue M; Ozaki S Cell Immunol; 2011; 272(1):11-7. PubMed ID: 22030472 [TBL] [Abstract][Full Text] [Related]
10. Role of the HTLV-1 viral factors in the induction of apoptosis. Karimi M; Mohammadi H; Hemmatzadeh M; Mohammadi A; Rafatpanah H; Baradaran B Biomed Pharmacother; 2017 Jan; 85():334-347. PubMed ID: 27887847 [TBL] [Abstract][Full Text] [Related]
11. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450 [TBL] [Abstract][Full Text] [Related]
12. HTLV-1-associated diseases. Watanabe T Int J Hematol; 1997 Oct; 66(3):257-78. PubMed ID: 9401272 [TBL] [Abstract][Full Text] [Related]
13. Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules. Teruya H; Tomita M; Senba M; Ishikawa C; Tamayose M; Miyazato A; Yara S; Tanaka Y; Iwakura Y; Fujita J; Mori N Retrovirology; 2008 Sep; 5():86. PubMed ID: 18808681 [TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia. Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424 [TBL] [Abstract][Full Text] [Related]
15. Immunological risks of adult T-cell leukemia at primary HTLV-I infection. Kannagi M; Ohashi T; Harashima N; Hanabuchi S; Hasegawa A Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062 [TBL] [Abstract][Full Text] [Related]
16. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Verdonck K; González E; Van Dooren S; Vandamme AM; Vanham G; Gotuzzo E Lancet Infect Dis; 2007 Apr; 7(4):266-81. PubMed ID: 17376384 [TBL] [Abstract][Full Text] [Related]
17. Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Xu X; Heidenreich O; Kitajima I; McGuire K; Li Q; Su B; Nerenberg M Oncogene; 1996 Jul; 13(1):135-42. PubMed ID: 8700539 [TBL] [Abstract][Full Text] [Related]
18. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511 [TBL] [Abstract][Full Text] [Related]
19. Role of microRNAs in HTLV-1 infection and transformation. Ruggero K; Corradin A; Zanovello P; Amadori A; Bronte V; Ciminale V; D'Agostino DM Mol Aspects Med; 2010 Oct; 31(5):367-82. PubMed ID: 20600265 [TBL] [Abstract][Full Text] [Related]
20. Human T-cell leukemia virus type I and adult T-cell leukemia. Matsuoka M Oncogene; 2003 Aug; 22(33):5131-40. PubMed ID: 12910250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]